Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)
1 clinical trials · Condition
◉ Watch Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)
| Record | Firm | Date |
|---|---|---|
| A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC (NCT07058519) | Shanghai Chest Hospital | 2025-09-23 |
Track Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC) automatically
Every clearance here is in the API, with alerts when new ones post.